March 29, 2021 – Philadelphia, PA – We are pleased to announce that Ms. Michie Ong will be joining WuXi Advanced Therapies Unit (WuXi ATU), as Senior Director of Global Quality and Compliance. In this role, Ms. Michie Ong will be responsible for setting the...
March 4, 2021 – Philadelphia, PA – We are pleased to announce that Ms. Haiyan Liu will be joining WuXi Advanced Therapies Unit (WuXi ATU), as Executive Director of Analysis and Testing. Ms. Haiyan Liu will be leading WuXi ATU China Analytical Development and...
PHILADELPHIA and OXFORD, March 2, 2021 – WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, today announced that it has completed the acquisition of OXGENE, a...
February 22, 2021 – Philadelphia, PA – We are pleased to announce that James Chen will be joining WuXi Advanced Therapies Unit (WuXi ATU), as Senior Director of Quality. Mr. James Chen will be leading WuXi ATU China Quality organization and working closely with...
January 4, 2021 – Philadelphia, PA – We are pleased to announce that Dr. Angela Chen will be joining WuXi Advanced Therapies Unit (WuXi ATU), as General Manager of WuXi ATU in China and Asian Commercial Head. Dr. Angela Chen brings strong leadership and a wealth of...
January 25, 2021 – Philadelphia, PA – We are pleased to announce that Dr. Weiwei Hu will be joining WuXi Advanced Therapies Unit (WuXi ATU), as Vice President, China Process Development and Tech Transfer Head. Dr. Weiwei Hu brings extensive industry experience in...
